Nombre del producto:tert-butyl N-[3-bromo-2-fluoro-4-(trifluoromethyl)phenyl]-N-tert-butoxycarbonyl-carbamate

IUPAC Name:tert-butyl N-[3-bromo-2-fluoro-4-(trifluoromethyl)phenyl]-N-[(tert-butoxy)carbonyl]carbamate

CAS:2940937-36-8
Fórmula molecular:C17H20BrF4NO4
Pureza:97%
Número de catálogo:CM1076284
Peso molecular:458.25

Unidad de embalaje Stock disponible Precio($) Cantidad
CM1076284-100mg in stock ƀȁȁ
CM1076284-250mg in stock Ŵǧƀ
CM1076284-500mg in stock ƙțƻ
CM1076284-1g in stock țțǧNJ
CM1076284-5g in stock ƀŴNJƻ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2940937-36-8
Fórmula molecular:C17H20BrF4NO4
Punto de fusión:-
Código de sonrisas:CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)C1=CC=C(C(Br)=C1F)C(F)(F)F
Densidad:
Número de catálogo:CM1076284
Peso molecular:458.25
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Fluorinated Compounds
Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.